RWJ-67657
CAS: 215303-72-3
Ref. TM-T16812
| 2mg | 46.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 212.00 € | ||
| 50mg | 344.00 € | ||
| 100mg | 551.00 € | ||
| 500mg | 1,161.00 € | ||
| 1ml*10 (DMSO) | 75.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
Product Information
Name:
RWJ-67657
Synonyms:
- JNJ 3026582
- 3-Butyn-1-ol, 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-
- 4-(4-Fluorophenyl)-2-(4-hydroxy-1-butynyl)-1-(3-Phenylpropyl)-5-(4-Pyridyl)imidazole
- 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-pyridin-4-yl-1H-imidazol-2-yl]but-3-yn-1-ol
- Jnj 3026582
- Rwj-67657
CAS:
Description:
RWJ-67657 (JNJ 3026582) is an orally active and selective p38α and p38β MAPK inhibitor (IC50s: 1 and 11 μM, respectively). RWJ-67657 shows no activity at p38γ and p38δ and shows a cardioprotective effect.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
425.5
Formula:
C27H24FN3O
Purity:
98.28%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T16812 RWJ-67657
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
